CathWorks

CathWorks
Medical technology company optimizing coronary artery disease therapy decisions with FFR-based assessment.
About
What does CathWorks do?
CathWorks develops a drug-free, wire-free system that combines artificial intelligence and computational science to obtain physiologic information from routine angiograms. Their FFRangio® System provides physicians with a quick and reliable intraprocedural physiologic assessment for the entire coronary tree, enhancing decision-making for treating Coronary Artery Disease. This technology serves interventional cardiologists and their patients by offering a less invasive and more comprehensive appr…
What is CathWorks's revenue?
StartupHub estimates CathWorks's annual revenue at $15.0M (range $7.9M to $21.8M, 66% confidence), based on comparable companies in the sector.
What is CathWorks's valuation?
StartupHub estimates CathWorks's effective valuation at $679.3M (range $389.5M to $934.8M, 10% confidence), based on comparable companies in the sector.
How much funding has CathWorks raised?
CathWorks has raised a total of $156M in funding. The most recent round on record is Strategic.
Where is CathWorks headquartered?
CathWorks is headquartered in Tel Aviv, Israel.
When was CathWorks founded?
CathWorks was founded in 2003.
What industry does CathWorks operate in?
CathWorks operates in Healthcare, Medical Imaging, 3D, MedTech, HealthTech, Cardiology.
How many employees does CathWorks have?
CathWorks has approximately 80 people on record.
No comments yet. Be the first to share your take.
